3NT Medical (3NT) announced today the initial closing of a major portion of its $15 million financing round from Hoya Corporation. The funds will be used to complete 3NT’s family of speciality single-use endoscopes and therapeutic devices and initiate commercialization of the SinuswayTM platform in the U.S. and Europe, advancing care of ear, nose and throat (ENT) disorders.

The company reports the financing round was led by HOYA Corporation (“HOYA”) and is its first venture investment in an Israeli company. HOYA joins current investors LongTec China Ventures and an elite group of angel investors, medical device industry veterans and ENT practitioners in their support of the company.

“We are honored to have HOYA join our team of investors. their investment is a strong validation of the team’s efforts to establish single-use endoscopy platforms as the next standard of care in ENT”, said Ehud Bendory, 3NT Chief Executive Officer.

“HOYA’s investment in 3NT continues our commitment to partner with innovative medical device companies that align with our core strategic areas of interest”, added Augustine Yee, Chief Legal Officer and Global Head of Corporate Development at HOYA. “We are excited about 3NT’s disruptive visualization technologies, and the benefits their devices will bring to ENT surgeons and their patients.”